Inventor · disambiguated record
Richard Wooster
Also filed as: WOOSTER RICHARD · WOOSTER RICHARD FRANCIS
15 granted patents·33 pending applications·58 citations·filing 1996–2025
90Inventor score
Files withTARVEDA THERAPEUTICS INC22TVA ABC LLC6PLACON THERAPEUTICS INC5TRANSLATE BIO INC5BLEND THERAPEUTICS INC2
Top patents by PatentIndex Score
48 records- 0187US9750818B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·6 cites·2 claims
- 0286US10624967B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·8 claims
- 0382US10322191B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·5 claims
- 0480US10548881B2HSP90 targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 4, 2020·1 cites·32 claims
- 0579US11241500B2HSP90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 8, 2022·1 cites·19 claims
- 0679US8580497B2Methods for detection of the oncogenic T1796A B-Raf mutationSTRATTON MIKE·Filed 2010·Granted Nov 12, 2013·5 cites·3 claims
- 0777US9937187B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·2 cites·20 claims
- 0876US2020121808A1Sstr-targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0976US2025057765A1Compositions, methods and uses of messenger rnaTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 1074US10322137B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·1 cites·7 claims
- 1174US7947819B2B-raf polynucleotidesWELLCOME TRUST·Filed 2004·Granted May 24, 2011·8 cites·3 claims
- 1273US2022288229A1Targeted conjugates encapsulated in particles and formulations thereofTVA ABC LLC·Filed 2022·Application pending·0 cites
- 1370US11510910B2HSP90 targeted conjugates and particles and formulations thereofTVA ABC LLC·Filed 2019·Granted Nov 29, 2022·0 cites·19 claims
- 1466US12076438B2Compositions, methods and uses of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 1564US11458206B2Targeted conjugates and particles and formulations thereofTVA ABC LLC·Filed 2020·Granted Oct 4, 2022·0 cites·6 claims
- 1664US2022096640A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1763US2022096646A1Sstr-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1861US6045997AMaterials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereofUNIV DUKE·Filed 1996·Granted Apr 4, 2000·29 cites·6 claims
- 1961US2022395498A1Targeted therapeuticsTVA ABC LLC·Filed 2022·Application pending·0 cites
- 2060US2014187501A1Targeted Conjugates Encapsulated in Particles and Formulations ThereofBLEND THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2159US2018021454A1Targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2258US2019350940A1Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2358US2025387492A1Hsp90-targeting conjugates and formulations thereofFUSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2456US11160871B2SSTR-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Nov 2, 2021·0 cites·10 claims
- 2555US2020230126A1Targeted therapeuticsTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2654US2016074526A1Sstr-targeted conjugates encapsulated in particles and formulations thereofBLEND THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2754US2025268994A1Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion ThereofTRANSLATE BIO INC·Filed 2022·Application pending·0 cites
- 2852US2021145971A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2951US2021145860A1Compositions, methods and uses of messenger rnaTRANSLATE BIO INC·Filed 2020·Application pending·0 cites
- 3050US2004096855A1GenesFiled 2003·Application pending·0 cites
- 3149US2021186978A1Combination therapyTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3248US2020237746A1Hsp90 targeted conjugates and particle formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3347US2024197825A1mRNA Encoding Engineered CFTRTRANSLATE BIO INC·Filed 2020·Application pending·0 cites
- 3446US10342801B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2016·Granted Jul 9, 2019·0 cites·8 claims
- 3546US2020230247A1Combination therapies comprising targeted therapeuticsTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3645US2019365913A1Stapled peptide conjugates and particlesTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3743US2022257777A1Hsp90-binding conjugates and combination therapies thereofTVA ABC LLC·Filed 2020·Application pending·0 cites
- 3843US2018296685A1Targeted constructs and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3943US2018221503A1Compositions and methods for immuno-oncology therapiesTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4043US2020078468A1Neurotensin receptor binding conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4142US2008206248A1Mutations in ErbB2 associated with cancerous phenotypesSTRATTON MICHAEL·Filed 2007·Application pending·0 cites
- 4241US2019085034A1Antibody mimic conjugates and particlesTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4341US2022257766A1Sstr-targeted conjugates and formulations thereofTVA ABC LLC·Filed 2020·Application pending·0 cites
- 4441US2021000966A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4541US2015051215A1Pi3k inhibitors for treating fibrotic diseasesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2013·Application pending·0 cites
- 4638US2017151339A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4736US2018186823A1Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4834US2016067247A1Novel useGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Wooster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →